CD44 and cancer: Several single-cell sequencing studies have also shown that SPP1/CD44-mediated intercellular interactions between macrophages and cancer cells promote the remodeling of the ECM, forming a plastic suppressive microenvironment, and preventing lymphocyte infiltration into the tumor core, further reducing the efficacy of PD-L1 therapy [53, 54].